Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Corbus Pharma (CRBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 400,551
  • Shares Outstanding, K 54,870
  • Annual Sales, $ 1,910 K
  • Annual Income, $ -20,000 K
  • 36-Month Beta 2.30
  • Price/Sales 206.74
  • Price/Cash Flow N/A
  • Price/Book 11.31

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.63 +11.85%
on 11/16/17
7.95 -6.72%
on 11/30/17
+0.82 (+12.36%)
since 11/15/17
3-Month
6.40 +15.87%
on 11/15/17
8.75 -15.25%
on 10/19/17
+0.67 (+9.86%)
since 09/15/17
52-Week
5.30 +39.92%
on 05/09/17
10.50 -29.38%
on 03/21/17
-1.33 (-15.25%)
since 12/15/16

Most Recent Stories

More News
Corbus Pharmaceuticals Initiates "RESOLVE-1" Phase 3 Study in Systemic Sclerosis

NORWOOD, MA--(Marketwired - December 14, 2017) -

CRBP : 7.40 (+1.37%)
Legal Cannabis Sales Grow Globally

According to a report published by Grand View Research, the global medical cannabis market is expected to reach USD 55.8 billion by 2025. Rising awareness of various medical applications in cannabis is...

KSHB : 2.9100 (-0.34%)
CRBP : 7.40 (+1.37%)
XXII : 2.68 (+2.68%)
ZYNE : 11.87 (+3.94%)
DJACF : 1.0190 (-0.10%)
Companies With Very Interesting CBD Technology

Technological advancement is always something that separates the great companies from the average ones. In today's world it seems as if there are massive leaps being made on a daily basis by companies...

CRBP : 7.40 (+1.37%)
ACBFF : 5.5000 (-1.43%)
GWPH : 129.62 (-0.92%)
INSY : 6.08 (+0.83%)
NGTF : 0.1466 (+4.71%)
Cannabis Sales Expected to Grow Due to Medical Benefits

According to Hexa Research, the U.S. medical cannabis market size was valued at USD $5.44 Billion in 2016 and is expected to hit USD $19.48 billion by 2024. The industry is expected to witness rapid growth...

NUVPD : 0.1543 (-9.24%)
EMHTF : 3.8200 (-1.61%)
CRBP : 7.40 (+1.37%)
NUVPF : 0.2580 (-7.86%)
XXII : 2.68 (+2.68%)
ZYNE : 11.87 (+3.94%)
Corbus Pharmaceuticals Holdings, Inc. Announces Exercise of Option to Purchase Additional Shares in Public Offering

NORWOOD, MA--(Marketwired - November 27, 2017) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious...

CRBP : 7.40 (+1.37%)
Legal Cannabis Medical Market Shows Strong Growth

According to a report by Forbes, Brightfield Group, a cannabis market research firm indicates that the international market for cannabis is projected to hit $31.4 billion by 2021. Bethany Gomez, Director...

CRBP : 7.40 (+1.37%)
VRTHF : 0.4712 (-2.64%)
AXIM : 7.4000 (+5.71%)
STVFD : 0.6400 (+4.92%)
VBIO : 1.7300 (+3.59%)
ZYNE : 11.87 (+3.94%)
Corbus Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference

NORWOOD, MA--(Marketwired - November 15, 2017) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious...

CRBP : 7.40 (+1.37%)
Corbus Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference

NORWOOD, MA--(Marketwired - November 09, 2017) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious...

CRBP : 7.40 (+1.37%)
Corbus Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference

NORWOOD, MA--(Marketwired - November 09, 2017) - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious...

CRBP : 7.40 (+1.37%)
Taking A Closer Look at CBD Companies

LAS VEGAS, November 8, 2017 /PRNewswire/ --

CRBP : 7.40 (+1.37%)
GWPH : 129.62 (-0.92%)
INSY : 6.08 (+0.83%)
ABBV : 97.59 (+1.34%)
NGTF : 0.1466 (+4.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Corbus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics to treat life threatening (`orphan`) inflammatory-fibrotic diseases. The Company's lead product is Resunab (TM), an oral anti-inflammatory drug that has completed...

See More

Key Turning Points

2nd Resistance Point 7.83
1st Resistance Point 7.57
Last Price 7.40
1st Support Level 7.12
2nd Support Level 6.93

See More

52-Week High 10.50
Fibonacci 61.8% 8.51
Fibonacci 50% 7.90
Last Price 7.40
Fibonacci 38.2% 7.29
52-Week Low 5.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.